SlideShare una empresa de Scribd logo

Bangladesh pharmaceutical export business 2012

•
•
Mohammad Masum Chowdhury
Mohammad Masum Chowdhury
1 de 1
Sl. Name of Pharmaceutical Companies Taka 1 Beximco Pharmaceuticals Ltd. 1,043,120,000 2 Novartis (BD) Limited. 824,523,034 3 Incepta Pharmaceuticals Ltd. 480,865,794 4 Square Pharmaceuticals Ltd. (Pabna Unit) 471,389,095 5 Techno Drugs Ltd. 350,943,600 6 Square Pharmaceuticals Ltd. (Gazipur Unit) 283,296,640 7 Renata Ltd. 267,878,584 8 The ACME Laboratories Ltd. 235,489,198 9 Skayef Bangladesh Ltd. 169,116,261 10 Aristropharma Ltd. 168,500,988 11 Jayson Pharmaceuticals Ltd. 128,083,402 12 Global Capsules Ltd. 116,030,480 13 Opsonin Pharmaceuticals Ltd. 100,098,606 14 ACI Pharmaceuticals Ltd. 96,445,805 15 General Pharmaceuticals Ltd. 89,205,112 16 Popular Pharmaceuticals Ltd. 66,243,373 17 Biopharma Laboratories Ltd. 64,445,440 18 Glaxo Bangladesh Ltd. 43,278,543 19 Orion Pharmaceuticals Ltd. 43,095,744 20 Navana Pharmaceuticals Ltd. 41,310,000 21 Globe Pharmaceuticals Ltd. 41,000,000 22 Healthcare Pharmaceuticals Ltd. 40,251,258 23 Sanofi Aventis (BD) Ltd. 38,456,934 24 Delta Pharma Ltd. 32,600,000 25 Square Cephalosporins Ltd. 31,391,936 26 Drugs International Ltd. 30,930,577 27 Beacon Pharmaceuticals Ltd. 21,536,080 28 IBN Sina Pharmaceuticals Ltd. 20,486,660 29 Edruc Limited. 14,925,836 30 Remon Drug Ltd. 10,049,757 31 Medicon Pharmaceuticals Ltd. 7,399,967 32 Novo Healthcare & Pharmaceuticals Ltd. 5,003,640 33 Somatec Pharmaceuticals Ltd. 4,629,638 34 Ziska Pharmaceuticals Ltd. 3,580,940 35 Radiant Pharmaceuticals Ltd. 3,388,896 36 Alco Pharmaceuticals Ltd. 2,689,600 37 Popular Infusions Ltd. 2,463,000 38 Modern Pharmaceuticals Ltd. 1,550,000 39 Amico Laboratories Ltd. 518,400 40 Grand Total 5,396,212,818 Source:DGDA, Bangladesh Bangladesh Pharmaceutical Export Statistics - 2012 ( January 20 12 to December 2012) Masum Chowdhury, Manager, SBM, Asiatic - masum.pha@gmail.com

Recomendados

African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation
PharmaAfrica
 
Regulatory Procedures
Regulatory ProceduresRegulatory Procedures
Regulatory Procedures
EURORDIS Rare Diseases Europe
 
DRAP Product Registration Flow Chart
DRAP Product Registration Flow Chart DRAP Product Registration Flow Chart
DRAP Product Registration Flow Chart
Muhammad Ali Jehangir
 
Pharmaceutical market of Uzbekistan
Pharmaceutical market of UzbekistanPharmaceutical market of Uzbekistan
Pharmaceutical market of Uzbekistan
VAYTON
 
Auditing of manufacturing facilities by international regulatory agencies ppt
Auditing of manufacturing facilities by international regulatory agencies pptAuditing of manufacturing facilities by international regulatory agencies ppt
Auditing of manufacturing facilities by international regulatory agencies ppt
Tek kaushik
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - Introduction
Dr. Jigar Vyas
 
Clinical Trial Requirements U.S. vs. EU Similarities and Differences
Clinical Trial Requirements U.S. vs. EU Similarities and DifferencesClinical Trial Requirements U.S. vs. EU Similarities and Differences
Clinical Trial Requirements U.S. vs. EU Similarities and Differences
RETIRE
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
Shoba Elangovan
 

Recomendados

African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation
PharmaAfrica
 
Regulatory Procedures
Regulatory ProceduresRegulatory Procedures
Regulatory Procedures
EURORDIS Rare Diseases Europe
 
DRAP Product Registration Flow Chart
DRAP Product Registration Flow Chart DRAP Product Registration Flow Chart
DRAP Product Registration Flow Chart
Muhammad Ali Jehangir
 
Pharmaceutical market of Uzbekistan
Pharmaceutical market of UzbekistanPharmaceutical market of Uzbekistan
Pharmaceutical market of Uzbekistan
VAYTON
 
Auditing of manufacturing facilities by international regulatory agencies ppt
Auditing of manufacturing facilities by international regulatory agencies pptAuditing of manufacturing facilities by international regulatory agencies ppt
Auditing of manufacturing facilities by international regulatory agencies ppt
Tek kaushik
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - Introduction
Dr. Jigar Vyas
 
Clinical Trial Requirements U.S. vs. EU Similarities and Differences
Clinical Trial Requirements U.S. vs. EU Similarities and DifferencesClinical Trial Requirements U.S. vs. EU Similarities and Differences
Clinical Trial Requirements U.S. vs. EU Similarities and Differences
RETIRE
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
Shoba Elangovan
 
Fda guidance for food and drug labelling professor pirouzi
Fda guidance for food and drug labelling professor pirouziFda guidance for food and drug labelling professor pirouzi
Fda guidance for food and drug labelling professor pirouzi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...
Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...
Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...
Nick DeSanctis
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
Girish Swami
 
FDA Regulation of Drug and Device Advertising and Promotion -- The Basics
FDA Regulation of Drug and Device Advertising and Promotion -- The BasicsFDA Regulation of Drug and Device Advertising and Promotion -- The Basics
FDA Regulation of Drug and Device Advertising and Promotion -- The Basics
Michael Swit
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouziFda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Anda submissions – refuse to-receive standards
Anda submissions – refuse to-receive standards Anda submissions – refuse to-receive standards
Anda submissions – refuse to-receive standards
Rumel Dey
 
Marketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countriesMarketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countries
Srinivasa Rao Moturi
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
Sigma
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
marchell
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
Industry Standard Research
 
Comparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & EuropeComparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & Europe
Chandra Mohan
 
Best Practices for Preparing and Conducting Pre-Submission Meetings
Best Practices for Preparing and Conducting Pre-Submission MeetingsBest Practices for Preparing and Conducting Pre-Submission Meetings
Best Practices for Preparing and Conducting Pre-Submission Meetings
Greenlight Guru
 
Anda refuse to receive
Anda refuse to receiveAnda refuse to receive
Anda refuse to receive
santoshnarla
 
Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela SaleemRegulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
AneelaSaleem
 
US FDA Regulatory Submissions
US FDA Regulatory SubmissionsUS FDA Regulatory Submissions
US FDA Regulatory Submissions
Chandra Mohan
 
New Directions in Drug Approval in Canada
New Directions in Drug Approval in CanadaNew Directions in Drug Approval in Canada
New Directions in Drug Approval in Canada
Canadian Cancer Survivor Network
 
Drug Master Files under GDUFA
Drug Master Files under GDUFADrug Master Files under GDUFA
Drug Master Files under GDUFA
GMP EDUCATION : Not for Profit Organization
 
Safety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. acoSafety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. aco
Azierta
 
Good distribution practices for API's
Good distribution practices for API'sGood distribution practices for API's
Good distribution practices for API's
GMP EDUCATION : Not for Profit Organization
 
Comparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japanComparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japan
sandeep bansal
 
Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...
Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...
Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...
Healthcare DENMARK
 
Export potentiality of pharmaceutical goods in bangladesh
Export potentiality of pharmaceutical goods in bangladeshExport potentiality of pharmaceutical goods in bangladesh
Export potentiality of pharmaceutical goods in bangladesh
Md.Shahed Jurain Alam
 

Más contenido relacionado

La actualidad más candente

Marketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countriesMarketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countries
Srinivasa Rao Moturi
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
Industry Standard Research
 
New Directions in Drug Approval in Canada
New Directions in Drug Approval in CanadaNew Directions in Drug Approval in Canada
New Directions in Drug Approval in Canada
Canadian Cancer Survivor Network
 

La actualidad más candente (20)

Fda guidance for food and drug labelling professor pirouzi
Fda guidance for food and drug labelling professor pirouziFda guidance for food and drug labelling professor pirouzi
Fda guidance for food and drug labelling professor pirouzi
 
Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...
Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...
Effective Pharmaceutical Life Cycle Management Planning: Optimizing Product V...
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
 
FDA Regulation of Drug and Device Advertising and Promotion -- The Basics
FDA Regulation of Drug and Device Advertising and Promotion -- The BasicsFDA Regulation of Drug and Device Advertising and Promotion -- The Basics
FDA Regulation of Drug and Device Advertising and Promotion -- The Basics
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouziFda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
 
Anda submissions – refuse to-receive standards
Anda submissions – refuse to-receive standards Anda submissions – refuse to-receive standards
Anda submissions – refuse to-receive standards
 
Marketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countriesMarketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countries
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 
Regulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and StructuresRegulatory Affairs: Department Models and Structures
Regulatory Affairs: Department Models and Structures
 
Comparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & EuropeComparison of Drug Approval Process in United States & Europe
Comparison of Drug Approval Process in United States & Europe
 
Best Practices for Preparing and Conducting Pre-Submission Meetings
Best Practices for Preparing and Conducting Pre-Submission MeetingsBest Practices for Preparing and Conducting Pre-Submission Meetings
Best Practices for Preparing and Conducting Pre-Submission Meetings
 
Anda refuse to receive
Anda refuse to receiveAnda refuse to receive
Anda refuse to receive
 
Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela SaleemRegulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
 
US FDA Regulatory Submissions
US FDA Regulatory SubmissionsUS FDA Regulatory Submissions
US FDA Regulatory Submissions
 
New Directions in Drug Approval in Canada
New Directions in Drug Approval in CanadaNew Directions in Drug Approval in Canada
New Directions in Drug Approval in Canada
 
Drug Master Files under GDUFA
Drug Master Files under GDUFADrug Master Files under GDUFA
Drug Master Files under GDUFA
 
Safety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. acoSafety reports. addendum to the clinical overview. aco
Safety reports. addendum to the clinical overview. aco
 
Good distribution practices for API's
Good distribution practices for API'sGood distribution practices for API's
Good distribution practices for API's
 
Comparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japanComparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japan
 

Destacado

Pharmaceutical Export Documentation, Procedure and Incoterms
Pharmaceutical Export Documentation, Procedure and IncotermsPharmaceutical Export Documentation, Procedure and Incoterms
Pharmaceutical Export Documentation, Procedure and Incoterms
Muhammad Ali Jehangir
 
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Irish Pereira
 

Destacado (8)

Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...
Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...
Thomas Klit Christensen's presentation from the Healthcare DENMARK Ambassador...
 
Export potentiality of pharmaceutical goods in bangladesh
Export potentiality of pharmaceutical goods in bangladeshExport potentiality of pharmaceutical goods in bangladesh
Export potentiality of pharmaceutical goods in bangladesh
 
Pharmaceutical Export Documentation, Procedure and Incoterms
Pharmaceutical Export Documentation, Procedure and IncotermsPharmaceutical Export Documentation, Procedure and Incoterms
Pharmaceutical Export Documentation, Procedure and Incoterms
 
Holograms to authenticate and identify the counterfeit pharma export drugs
Holograms to authenticate and identify the counterfeit pharma export drugsHolograms to authenticate and identify the counterfeit pharma export drugs
Holograms to authenticate and identify the counterfeit pharma export drugs
 
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
 
Import and Export Process of Bangladesh
Import and Export Process of BangladeshImport and Export Process of Bangladesh
Import and Export Process of Bangladesh
 
Mobile Phone Industries of Bangladesh
Mobile Phone Industries of BangladeshMobile Phone Industries of Bangladesh
Mobile Phone Industries of Bangladesh
 
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overviewindian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overview
 

Más de Mohammad Masum Chowdhury

Secrets of a successful medical promotion officer
Secrets of a successful medical promotion officerSecrets of a successful medical promotion officer
Secrets of a successful medical promotion officer
Mohammad Masum Chowdhury
 
Advanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionalsAdvanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionals
Mohammad Masum Chowdhury
 

Más de Mohammad Masum Chowdhury (20)

Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
 
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
 
Bazarzarkaran February 2020
Bazarzarkaran February 2020Bazarzarkaran February 2020
Bazarzarkaran February 2020
 
Bazarzatkaran January 2020
Bazarzatkaran January 2020Bazarzatkaran January 2020
Bazarzatkaran January 2020
 
The Five Levels of Leadership by Md. Masum Chowdhury
The Five Levels of Leadership by Md. Masum Chowdhury The Five Levels of Leadership by Md. Masum Chowdhury
The Five Levels of Leadership by Md. Masum Chowdhury
 
Psycho Cybernetics or Self Image Management
Psycho Cybernetics or Self Image ManagementPsycho Cybernetics or Self Image Management
Psycho Cybernetics or Self Image Management
 
Professionalism practice in the workplace
Professionalism practice in the workplaceProfessionalism practice in the workplace
Professionalism practice in the workplace
 
E book personal core values, belief and brand
E book personal core values, belief and brandE book personal core values, belief and brand
E book personal core values, belief and brand
 
Dress slideshare .pdf
Dress slideshare .pdfDress slideshare .pdf
Dress slideshare .pdf
 
How to develop Rx share for continuous business growth
How to develop Rx share for continuous business growthHow to develop Rx share for continuous business growth
How to develop Rx share for continuous business growth
 
Pharmaceutical business strategy and policy 2015
Pharmaceutical business strategy and policy 2015 Pharmaceutical business strategy and policy 2015
Pharmaceutical business strategy and policy 2015
 
Advanced pharmaceutical selling skill
Advanced pharmaceutical selling skillAdvanced pharmaceutical selling skill
Advanced pharmaceutical selling skill
 
Masum personal profile
Masum personal profileMasum personal profile
Masum personal profile
 
Secrets of a successful medical promotion officer
Secrets of a successful medical promotion officerSecrets of a successful medical promotion officer
Secrets of a successful medical promotion officer
 
Advanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionalsAdvanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionals
 

Bangladesh pharmaceutical export business 2012

  • 1. Sl. Name of Pharmaceutical Companies Taka 1 Beximco Pharmaceuticals Ltd. 1,043,120,000 2 Novartis (BD) Limited. 824,523,034 3 Incepta Pharmaceuticals Ltd. 480,865,794 4 Square Pharmaceuticals Ltd. (Pabna Unit) 471,389,095 5 Techno Drugs Ltd. 350,943,600 6 Square Pharmaceuticals Ltd. (Gazipur Unit) 283,296,640 7 Renata Ltd. 267,878,584 8 The ACME Laboratories Ltd. 235,489,198 9 Skayef Bangladesh Ltd. 169,116,261 10 Aristropharma Ltd. 168,500,988 11 Jayson Pharmaceuticals Ltd. 128,083,402 12 Global Capsules Ltd. 116,030,480 13 Opsonin Pharmaceuticals Ltd. 100,098,606 14 ACI Pharmaceuticals Ltd. 96,445,805 15 General Pharmaceuticals Ltd. 89,205,112 16 Popular Pharmaceuticals Ltd. 66,243,373 17 Biopharma Laboratories Ltd. 64,445,440 18 Glaxo Bangladesh Ltd. 43,278,543 19 Orion Pharmaceuticals Ltd. 43,095,744 20 Navana Pharmaceuticals Ltd. 41,310,000 21 Globe Pharmaceuticals Ltd. 41,000,000 22 Healthcare Pharmaceuticals Ltd. 40,251,258 23 Sanofi Aventis (BD) Ltd. 38,456,934 24 Delta Pharma Ltd. 32,600,000 25 Square Cephalosporins Ltd. 31,391,936 26 Drugs International Ltd. 30,930,577 27 Beacon Pharmaceuticals Ltd. 21,536,080 28 IBN Sina Pharmaceuticals Ltd. 20,486,660 29 Edruc Limited. 14,925,836 30 Remon Drug Ltd. 10,049,757 31 Medicon Pharmaceuticals Ltd. 7,399,967 32 Novo Healthcare & Pharmaceuticals Ltd. 5,003,640 33 Somatec Pharmaceuticals Ltd. 4,629,638 34 Ziska Pharmaceuticals Ltd. 3,580,940 35 Radiant Pharmaceuticals Ltd. 3,388,896 36 Alco Pharmaceuticals Ltd. 2,689,600 37 Popular Infusions Ltd. 2,463,000 38 Modern Pharmaceuticals Ltd. 1,550,000 39 Amico Laboratories Ltd. 518,400 40 Grand Total 5,396,212,818 Source:DGDA, Bangladesh Bangladesh Pharmaceutical Export Statistics - 2012 ( January 20 12 to December 2012) Masum Chowdhury, Manager, SBM, Asiatic - masum.pha@gmail.com